COMPANY PROFILE // THE 014 REPORT
Aethlon Medical Inc.
AEMD (Nasdaq) · Formerly: BISHOP EQUITIES INC
Assembled from 4 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-10-01: a pattern of leadership change.
- Amber8-K Item 3.01 filed: notice of delisting, of a failed continued-listing rule, or of a transfer of listing on 2025-10-22 and 1 more time (last 24 months).
- AmberLEI 54930036LMXCIW3XG337 registration status is LAPSED (last update 2023-08-04): the legal-entity record has not been renewed.
✓ SEC filings✓ LEI✓ SAM registrationpossible match✓ State registrationpossible match✗ IRS return✗ Website✗ Lobbying registration
No IRS return, no website, no lobbying registration on record.
AETHLON MEDICAL INC is an SEC-registered operating company in pharmaceutical preparations, incorporated in NV, based in San Diego, CA; listed as AEMD (Nasdaq).[source] It has filed 72 documents with the SEC in the last 12 months; the latest is Form 8-K, filed 2026-11-16.[source] Seraphix flags 3 items from these records: 8-K Item 3.01 filed; 3 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-10-01; LEI 54930036LMXCIW3XG337 registration status is LAPSED (last update 2023-08-04).[source]
- red0
- amber3
- info0
- CLEAR25
- POSSIBLE MATCH1
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- BROENNIMAN EDWARD G · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
- Gikakis Nicolas · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
- Rossetti Angela · Director · latest Form 4 2025-04-25 · filing · LinkedIn search
- Shah Chetan · Director · latest Form 4 2026-01-02 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Links
- Official website (Wikidata or the SEC record)
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000882291 | source |
| LEI | 54930036LMXCIW3XG337 | source |
| UEIpossible match | MUNVGHPLRV56 | source |
| CAGEpossible match | 47A31 | source |
| EIN | 13-3632859 | source |
| California SOS entity | 2023005155 | record |
| California SOS entity | 2023005143 | record |
| California SOS entity | 2004005368 | record |
| Business address (SEC) | 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121 | source |
Does not exist in the records we hold: NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2017-03-24 · in -3,528 days · LEI next renewal (54930036LMXCIW3XG337)
- 2027-02-14 · in 86 days · Next 10-Q due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-06-29 · in 221 days · Next 10-K due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-07-08 · in 230 days · SAM registration expires (UEI MUNVGHPLRV56)possible match
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
ADDRESS · ZIP CODE
Location context
At the same address (2)
- VivoSim Labs, INC. · SEC registrant
Federal contractors nearby in the same code (90)
- SPARK MOLECULAR DIAGNOSTICS, INC · SAM Active
- BRAINXELL THERAPEUTICS, INC. · SAM Active
- ELECTRADX MOLECULAR LLC · SAM Active
- ZAFRENS INC. · SAM Active
- VALA SCIENCES INC. · SAM Active
- INVIVOGEN · SAM Active
- BEACON SCIENTIFIC INC · SAM Active
- BALLAD RESEARCH INSTITUTE · SAM Active
- NAVEGA THERAPEUTICS, INC. · SAM Active
- CYBELE MICROBIOME INC · SAM Expired
registered in SAM.gov with the same ZIP code (92121) and the same primary NAICS code (541714), extract 2026-11-01
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
SEC registrants at the same address
EVERY SOURCE · NEWEST FIRST
One timeline
- 2027-07-08 registration SAM registration expiry (UEI MUNVGHPLRV56) · SAM.gov
- 2026-11-16 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-11-12 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-11-12 filing S-8 · SEC EDGAR
- 2026-10-09 filing 8-K items 5.03,9.01 · SEC EDGAR
- 2026-10-05 filing 8-K/A items 5.07 · SEC EDGAR
- 2026-10-01 officer change 8-K items 5.02,5.07,9.01 · SEC EDGAR
- 2026-09-17 filing 425 · SEC EDGAR
- 2026-09-17 filing 8-K items 1.01,5.01,7.01,9.01 · SEC EDGAR
- 2026-09-15 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-09-04 filing DEFA14A · SEC EDGAR
- 2026-09-01 filing Proxy statement · SEC EDGAR
- 2026-08-31 filing 8-K items 8.01 · SEC EDGAR
- 2026-08-21 filing PRE 14A · SEC EDGAR
- 2026-08-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-13 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-07-31 filing 8-K items 3.03,5.03,9.01 · SEC EDGAR
- 2026-07-08 filing 8-K items 1.01,8.01,9.01 · SEC EDGAR
- 2026-07-07 filing 424B3 · SEC EDGAR
- 2026-07-06 filing EFFECT · SEC EDGAR
- 2026-07-01 filing S-1/A · SEC EDGAR
- 2026-07-01 filing S-1/A · SEC EDGAR
- 2026-06-22 filing Registration (S-1) · SEC EDGAR
- 2026-06-10 filing S-8 · SEC EDGAR
- 2026-06-10 filing Annual report (10-K) · SEC EDGAR
- 2026-06-10 filing 8-K items 2.02,7.01,9.01 · SEC EDGAR
- 2026-06-04 filing 8-K items 8.01,9.01 · SEC EDGAR
- 2026-06-04 filing 424B5 · SEC EDGAR
- 2026-05-05 filing DRS · SEC EDGAR
170 earlier entries
- 2026-03-17 filing 8-K items 8.01
- 2026-02-23 officer change 8-K items 5.02,5.03,5.07,9.01
- 2026-02-12 filing Quarterly report (10-Q)
- 2026-02-12 filing 8-K items 2.02,7.01,9.01
- 2026-01-27 filing 424B3
- 2026-01-27 filing DEFA14A
- 2026-01-26 filing 8-K items 1.01,9.01
- 2026-01-16 filing EFFECT
- 2026-01-16 filing 424B3
- 2026-01-16 filing Proxy statement
- 2026-01-14 filing CORRESP
- 2026-01-13 filing UPLOAD
- 2026-01-07 filing Registration (S-1)
- 2026-01-02 filing EFFECT
- 2025-12-30 filing CORRESP
- 2025-12-30 filing UPLOAD
- 2025-12-23 filing S-3
- 2025-12-23 filing D
- 2025-12-08 filing 8-K items 1.01,3.03,7.01,9.01
- 2025-11-12 filing Quarterly report (10-Q)
- 2025-11-12 filing 8-K items 2.02,7.01,9.01
- 2025-11-06 filing 8-K items 8.01
- 2025-10-22 filing 8-K items 3.01
- 2025-10-16 filing 8-K items 3.03,5.03,9.01
- 2025-09-12 filing 8-K items 8.01
- 2025-09-09 filing 8-K items 1.01,8.01,9.01
- 2025-09-05 filing 424B4
- 2025-09-04 filing EFFECT
- 2025-08-29 filing CORRESP
- 2025-08-29 filing CORRESP
- 2025-08-29 filing S-1/A
- 2025-08-21 filing 8-K items 7.01,9.01
- 2025-08-20 filing Registration (S-1)
- 2025-08-20 filing 1-A-W
- 2025-08-13 filing Quarterly report (10-Q)
- 2025-08-13 filing 8-K items 2.02,7.01,9.01
- 2025-07-29 filing UPLOAD
- 2025-07-25 filing DRS
- 2025-06-27 filing 8-K items 2.02,7.01,9.01
- 2025-06-26 filing Annual report (10-K)
- 2025-06-05 filing 8-K items 8.01
- 2025-05-13 filing 8-K items 5.07
- 2025-04-25 insider First Form 3/4/5 on record for Rossetti Angela (Director)
- 2025-04-18 filing Proxy statement
- 2025-04-08 filing PRE 14A
- 2025-04-01 insider First Form 3/4/5 on record for BROENNIMAN EDWARD G (Director)
- 2025-04-01 insider First Form 3/4/5 on record for Gikakis Nicolas (Director)
- 2025-04-01 insider First Form 3/4/5 on record for Shah Chetan (Director)
- 2025-03-17 filing 8-K items 1.01,3.02,3.03,9.01
- 2025-02-12 filing Quarterly report (10-Q)
- 2025-02-12 filing 8-K items 2.02,7.01,9.01
- 2025-01-30 filing 1-A/A
- 2025-01-08 filing 8-K items 3.01
- 2024-12-27 filing 1-A
- 2024-12-20 filing 8-K items 8.01,9.01
- 2024-11-15 filing S-8
- 2024-11-13 filing Quarterly report (10-Q)
- 2024-11-13 filing 8-K items 2.02,7.01,9.01
- 2024-11-12 filing 8-K items 8.01,9.01
- 2024-10-03 officer change 8-K items 5.02
- 2024-10-02 officer change 8-K items 5.02,5.07,9.01
- 2024-09-19 filing 8-K items 8.01,9.01
- 2024-08-15 filing ARS
- 2024-08-15 filing DEFA14A
- 2024-08-15 filing Proxy statement
- 2024-08-15 filing 10-K/A
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-08-14 filing 8-K items 2.02,7.01,9.01
- 2024-08-12 filing 8-K items 8.01,9.01
- 2024-07-03 filing 8-K items 4.01,9.01
- 2024-06-27 filing Annual report (10-K)
- 2024-06-27 filing 8-K items 2.02,9.01
- 2024-05-24 filing 8-K items 8.01
- 2024-05-17 filing 8-K items 8.01,9.01
- 2024-05-16 filing EFFECT
- 2024-05-16 filing 424B4
- 2024-05-15 filing EFFECT
- 2024-05-15 filing POS AM
- 2024-05-13 filing S-1/A
- 2024-05-10 filing CORRESP
- 2024-05-10 filing CORRESP
- 2024-05-10 filing 8-K items 8.01,9.01
- 2024-04-25 filing S-1/A
- 2024-04-25 filing 8-K items 8.01,9.01
- 2024-04-05 filing S-1/A
- 2024-03-28 filing UPLOAD
- 2024-03-22 filing Registration (S-1)
- 2024-02-14 filing Quarterly report (10-Q)
- 2024-02-14 filing 8-K items 2.02,9.01
- 2023-12-22 officer change 8-K/A items 5.02,9.01
- 2023-11-27 officer change 8-K items 5.02,9.01
- 2023-11-14 filing Quarterly report (10-Q)
- 2023-11-14 filing 8-K items 2.02,9.01
- 2023-11-13 officer change 8-K items 5.02
- 2023-10-04 filing 8-K items 8.01,9.01
- 2023-09-18 filing 8-K items 5.07
- 2023-08-10 filing Quarterly report (10-Q)
- 2023-08-10 filing 8-K items 2.02,9.01
- 2023-07-27 filing ARS
- 2023-07-27 filing Proxy statement
- 2023-07-17 filing PRE 14A
- 2023-07-06 officer change 8-K items 5.02
- 2023-06-28 filing Annual report (10-K)
- 2023-06-28 filing 8-K items 2.02,9.01
- 2023-04-25 filing 8-K items 8.01
- 2023-02-13 filing Quarterly report (10-Q)
- 2023-02-13 filing 8-K items 2.02,9.01
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-14 filing 8-K items 2.02,9.01
- 2022-10-27 filing 8-K items 3.01
- 2022-09-29 filing 8-K items 8.01,9.01
- 2022-09-29 filing 424B5
- 2022-09-29 filing 8-K items 8.01
- 2022-09-19 filing S-8
- 2022-09-19 officer change 8-K items 5.02,5.03,5.07,8.01,9.01
- 2022-08-09 filing Quarterly report (10-Q)
- 2022-08-09 filing 8-K items 2.02,9.01
- 2022-08-03 filing 424B5
- 2022-07-27 filing Proxy statement
- 2022-07-15 filing PRE 14A
- 2022-06-28 filing Annual report (10-K)
- 2022-06-28 filing 8-K items 2.02,9.01
- 2022-03-28 officer change 8-K items 5.02
- 2022-03-24 filing 8-K items 1.01,9.01
- 2022-03-24 filing 424B5
- 2022-02-14 filing Quarterly report (10-Q)
- 2022-02-14 filing 8-K items 2.02,9.01
- 2021-11-09 filing Quarterly report (10-Q)
- 2021-11-09 filing 8-K items 2.02,9.01
- 2021-11-01 filing 8-K items 1.01
- 2021-10-21 filing EFFECT
- 2021-09-30 filing S-3
- 2021-09-17 filing 8-K items 5.07
- 2021-08-09 filing Quarterly report (10-Q)
- 2021-08-09 filing 8-K items 2.02,9.01
- 2021-07-28 filing DEFA14A
- 2021-07-28 filing Proxy statement
- 2021-07-01 officer change 8-K items 5.02
- 2021-06-24 filing Annual report (10-K)
- 2021-06-24 filing 8-K items 2.02,9.01
- 2021-06-11 filing 8-K items 8.01,9.01
- 2021-06-11 filing 424B5
- 2021-03-22 filing 8-K items 1.01,9.01
- 2021-03-22 filing 424B5
- 2021-02-10 filing Quarterly report (10-Q)
- 2021-02-10 filing 8-K items 2.02,9.01
- 2021-01-11 filing 8-K items 7.01,9.01
- 2020-12-10 filing 8-K items 1.01
- 2020-11-03 officer change 8-K items 4.01,5.02,8.01,9.01
- 2020-10-28 filing Quarterly report (10-Q)
- 2020-10-28 filing 8-K items 2.02,9.01
- 2020-09-15 filing S-8
- 2020-09-15 officer change 8-K items 5.02,5.07,9.01
- 2020-08-11 filing Quarterly report (10-Q)
- 2020-08-11 filing 8-K items 2.02,9.01
- 2020-07-28 filing DEFA14A
- 2020-07-28 filing Proxy statement
- 2020-06-25 filing Annual report (10-K)
- 2020-06-25 filing 8-K items 2.02,9.01
- 2020-03-30 filing EFFECT
- 2020-03-30 filing 424B5
- 2020-03-26 filing CORRESP
- 2020-03-26 filing UPLOAD
- 2020-03-23 officer change 8-K items 5.02,9.01
- 2020-03-19 filing S-3
- 2020-02-21 officer change 8-K items 5.02
- 2020-02-10 filing Quarterly report (10-Q)
- 2020-02-10 filing 8-K items 2.02,5.05,9.01
- 2020-01-24 filing D
- 2020-01-22 filing 8-K items 3.02
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-16 (within 7 days) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 (within 30 days) 10-Q filed (FORM 10-Q FOR SEP 2026)
- 2026-11-12 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 (within 30 days) S-8 filed (FORM S-8)
- 2026-10-09 (older) 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-05 (older) 8-K/A filed: Item 5.07 shareholder vote
- 2026-10-01 (older) 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-09-17 (older) 425 filed (FORM 8-K)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NASDAQ:AEMD The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
10 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 882291 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | AEMD / Nasdaq | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 54930036LMXCIW3XG337 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 54930036LMXCIW3XG337) | GLEIF |
| EIN | 133632859 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000882291 | SEC EDGAR / IRS |
| CUSIP | 00808Y703 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000882291 | SEC EDGAR |
| UEI | MUNVGHPLRV56 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000882291 | USAspending |
possible match: matched by name only, not merged (5)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110071137458 (AETHLON MEDICAL INC) | name-exact:legal-name: same registered legal name as 'AETHLON MEDICAL INC' | EPA ECHO facilities |
| EPA FRS id | 110071213251 (AETHLON MEDICAL INC) | name-exact:legal-name: same registered legal name as 'AETHLON MEDICAL INC' | EPA ECHO facilities |
| EPA FRS id | 110070477837 (AETHLON MEDICAL INC) | name-exact:legal-name: same registered legal name as 'AETHLON MEDICAL INC' | EPA ECHO facilities |
| EPA FRS id | 110071455096 (AETHLON MEDICAL INC) | name-exact:legal-name: same registered legal name as 'AETHLON MEDICAL INC' | EPA ECHO facilities |
| EPA FRS id | 110071134229 (AETHLON MEDICAL INC) | name-exact:legal-name: same registered legal name as 'AETHLON MEDICAL INC' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Net income (loss) (fiscal year ended 2026-03-31) | -$7,151,469 | 2026-03-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-20 03:18 UTC | Report an error |
| Total assets (at 2026-03-31) | $6,333,107 | 2026-03-31 | 10-K, XBRL Assets | as filed | 2026-11-20 03:18 UTC | Report an error |
| Stockholders' equity (at 2026-03-31) | $4,886,272 | 2026-03-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-20 03:18 UTC | Report an error |
| Cash and cash equivalents (at 2026-03-31) | $5,026,458 | 2026-03-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-20 03:18 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| State of incorporation | NV | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| Fiscal year end (MMDD) | 0331 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| Business address | 11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA, 92121 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| Exchanges | Nasdaq | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-20 03:18 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2026-03-31) | -$6,998,392 | 2026-03-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-20 03:18 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2026-03-31) | $3,704 | 2026-03-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-20 03:18 UTC | Report an error |
| Operating lease liabilities (at 2026-03-31) | $336,718 | 2026-03-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-20 03:18 UTC | Report an error |
| Form D total offering amount (D filed 2025-12-23) | $2,153,700 | 2025-12-23 | D | as filed | 2026-11-20 03:18 UTC | Report an error |
| Form D total amount sold (D filed 2025-12-23) | $2,153,700 | 2025-12-23 | D | as filed | 2026-11-20 03:18 UTC | Report an error |
| Form D industry group | Biotechnology | 2025-12-23 | D | as filed | 2026-11-20 03:18 UTC | Report an error |
| Form D revenue range | No Revenues | 2025-12-23 | D | as filed | 2026-11-20 03:18 UTC | Report an error |
| Form D date of first sale | 2025-12-08 | 2025-12-23 | D | as filed | 2026-11-20 03:18 UTC | Report an error |
| Federal award transactions, fiscal year 2026 (this one registration only) | $0 | 2026-09-30 | USAspending recipient profile | as filed | 2026-11-20 03:18 UTC | Report an error |
| Number of federal award transactions, fiscal year 2026 (this one registration only) | 0 | 2026-09-30 | USAspending recipient profile | as filed | 2026-11-20 03:18 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001683168-26-008623
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Net income (loss) | -$2,617,507 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001683168-26-008623 | 2026-11-20 03:18 UTC | Report an error |
| Cash and cash equivalents | $6,486,639 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001683168-26-008623 | 2026-11-20 03:18 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-16 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 Filing 10-Q filed (FORM 10-Q FOR SEP 2026)
- 2026-11-12 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-11-12 Filing S-8 filed (FORM S-8)
- 2026-10-09 Filing 8-K filed: Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-10-05 Filing 8-K/A filed: Item 5.07 shareholder vote
- 2026-10-01 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2026-09-17 Filing 425 filed (FORM 8-K)
- 2026-09-17 Filing 8-K filed: Item 1.01 material agreement; Item 5.01 change in control; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-09-15 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-09-04 Filing DEFA14A filed (FORM DEFA14A)
- 2026-09-01 Filing DEF 14A filed (DEFINITIVE PROXY)
- 2026-08-31 Filing 8-K filed: Item 8.01 other event
- 2026-08-21 Filing PRE 14A filed (PRELIMINARY PROXY STATEMENT)
- 2026-08-13 Filing 10-Q filed (FORM 10-Q FOR JUN 2026)
- 2026-08-13 Filing 8-K filed: Item 2.02 results of operations; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-07-31 Filing 8-K filed: Item 3.03 rights of holders modified; Item 5.03 charter or bylaw amendment; Item 9.01 exhibits
- 2026-07-08 Filing 8-K filed: Item 1.01 material agreement; Item 8.01 other event; Item 9.01 exhibits
- 2026-07-07 Filing 424B3 filed (PROSPECTUS)
- 2026-07-06 Filing EFFECT filed
- 2026-07-01 Filing S-1/A filed (AMENDMENT NO 2)
- 2026-07-01 Filing S-1/A filed (AMENDMENT NO. 1)
- 2026-06-22 Filing S-1 filed (REGISTRATION STATEMENT)
- 2026-06-10 Filing S-8 filed (INITIAL REGISTRATION STATEMENT)
- 2026-06-10 Filing 10-K filed (FORM 10-K FOR MAR 2026)
8-K item text, as filed (excerpts)
- 2026-11-16 8-K Item 7.01, Regulation FD Disclosure
As previously announced, on September 17, 2026, Aethlon Medical, Inc., a Nevada corporation (the “Company”), Nighthawk Merger Sub Corp., a Delaware corporation and a wholly owned subsidiary of the Company (the “First Merger Sub”), Nighthawk Second Merger Sub, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company (the “Second Merger Sub” and, together with First Merger Sub, the “Merger Subs”), and North Immunology, Inc., a Delaware corporation (“North Immunology”), entered into an Agreement and Plan of Merger and Reorganization (the “Merger Agreement”), pursuant to which, among other matters and subject to the satisfaction or waiver of the conditions set… the 8-K · retrieved 2026-11-20 03:18 UTC - 2026-11-12 8-K Item 2.02, Results of Operations and Financial Condition
The information provided below in “Item 7.01 - Regulation FD Disclosure” of this Current Report on Form 8-K (this “Current Report”) is incorporated by reference into this Item 2.02. Item 7.01 Regulation FD Disclosure. On November 12, 2026, Aethlon Medical, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended September 30, 2026. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information set forth under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of… the 8-K · retrieved 2026-11-20 03:18 UTC - 2026-10-09 8-K Item 5.03, Amendments to Articles of Incorporation or Bylaws; Change
in Fiscal Year. As previously reported, at the 2026 Annual Meeting of Stockholders of Aethlon Medical, Inc. (the "Company") held on October 1, 2026, the Company's stockholders approved an amendment to the Company's Articles of Incorporation, as amended, to increase the number of authorized shares of the Company's common stock, par value $0.001 per share, from 20,000,000 shares to 200,000,000 shares (the "Articles Amendment"). The Articles Amendment was filed with the Secretary of State of the State of Nevada and became effective on October 7, 2026, and amends Article V of the Company’s Articles of Incorporation to authorize an aggregate of 200,000,000 shares of common stock, par value… the 8-K · retrieved 2026-11-20 03:18 UTC - 2026-10-05 8-K Item 5.07, Submission of Matters to a Vote of Security Holders
Proposal No. 7: The Company’s stockholders did not approve a proposed amendment to the Company's Articles of Incorporation to authorize 20,000,000 shares of preferred stock, par value $0.001 per share, and authorize the Board of Directors to establish one or more series thereof and to fix the designations, powers, preferences, rights, qualifications, limitations and restrictions of each such series, as follows: Votes For Votes Against Abstentions Broker Non-Votes 204,122 9,529 1,555 184,547 Approval of Proposal No. 7 required the affirmative vote of holders of a majority of the outstanding shares of the Company’s common stock entitled to vote on the proposal. As of August 10, 2026, the… the 8-K · retrieved 2026-11-20 03:18 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (5)
possible match: matched by name only, not merged (5)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchAETHLON MEDICAL INC · exact legal name · sx:epa:110071137458 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:epa:110071213251 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:epa:110070477837 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:epa:110071455096 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:epa:110071134229 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Aethlon Medical, Inc. · LEI 54930036LMXCIW3XG337 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
5 state and city records carry this company's exact name, from 3 sources. Possible matches only.
California business registrations (3)
possible match: matched by name only, not merged (3)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchAETHLON MEDICAL INC · exact legal name · sx:cabiz:sd:2023005155 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:cabiz:sd:2023005143 Compare
- possible matchAETHLON MEDICAL INC · exact legal name · sx:cabiz:sd:2004005368 Compare
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchAethlon Medical Inc. · exact legal name · sx:ctgov:h686a6395cb8dec1b Compare
USAspending (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchAETHLON MEDICAL INC · exact legal name · sx:usaspending:MUNVGHPLRV56 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/882291.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000882291. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.